Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 160

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks

Open access
ROSTOM, A., MOAYYEDI, P., HUNT, R., FOR THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY CONSENSUS GROUP · 2009 · Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background Nonsteroidal anti‐inflammatory drugs (NSAIDs) are widely used, but are not without risks. Aim To provide evidence‐based management recommendations to help clinicians determine optimal long‐term NSAID therapy and the need for gastroprotective strategies based on an assessment of both gastrointestinal (GI) and cardiovascular (CV) risks. Methods A multidisciplinary group of 21 voting participants revised and voted on the statements and the strength of evidence (assessed according to GRADE) at a consensus meeting. Results An algorithmic approach was developed to help manage patients who require long‐term NSAID therapy. The use of low‐dose acetylsalicylic acid in patients with high CV risk was assumed. For patients at low GI and CV risk, a traditional NSAID alone may be acceptable. For patients with low GI risk and high CV risk, full‐dose naproxen may have a lower potential for CV risk than other NSAIDs. In patients with high GI and low CV risk, a COX‐2 inhibitor plus a proton pump inhibitor (PPI) may offer the best GI safety profile. When both GI and CV risks are high and NSAID therapy is absolutely necessary, risk should be prioritized. If the primary concern is GI risk, a COX‐2 inhibitor plus a PPI is recommended; if CV risk, naproxen 500 mg b.d. plus a PPI would be preferred. NSAIDs should be used at the lowest effective dose for the shortest possible duration. Conclusion More large, long‐term trials that examine clinical outcomes of complicated and symptomatic upper and lower GI ulcers are needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2008.03905.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 160

Metadata

Authors
ROSTOM, A., MOAYYEDI, P., HUNT, R., & FOR THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY CONSENSUS GROUP
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2009-01-30
Volume
29
Issue
5
Pages
481-496
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1986727655
Cited by
160
References
3
FWCI
8.48
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks. https://app.cochat.ai/papers/10.1111/j.1365-2036.2008.03905.x
The paper
ROSTOM, A., MOAYYEDI, P., HUNT, R., & FOR THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY CONSENSUS GROUP. (2009). Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2008.03905.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.